How Are Snack Giants Surviving GLP-1 Appetite Suppressants? Industry Reformulation Strategies in 2025

What Is the GLP-1 Crisis Facing Snack Companies?

The snack food industry faces its most significant disruption since the low-fat craze of the 1990s.

GLP-1 medications like Ozempic, Wegovy, and Mounjaro have fundamentally altered how 15.5 million Americans eat.

These drugs work by mimicking hormones that regulate appetite, creating a physiological reduction in hunger.

According to research from Morgan Stanley published in September 2024, GLP-1 users report a 25-40% reduction in snack food consumption.

The impact extends beyond simple calorie reduction.

Users specifically report decreased cravings for highly processed, high-sugar, and high-fat foods.

Goldman Sachs projects this number will reach 30 million by 2028.

JPMorgan analyst Ken Goldman called it “an existential moment for packaged food.”

The crisis accelerated faster than anyone predicted.

In 2023, most food executives dismissed GLP-1 concerns as overblown.

By mid-2024, those same executives scrambled to reformulate their entire product portfolios.

How Big Is the Financial Impact on the Snack Industry?

this recipe

The numbers tell a stark story of an industry under pressure.

The U.S. snack food market, valued at $148 billion in 2024, experienced its first volume decline in 15 years.

Total snack volumes fell 3.2% year-over-year, according to Nielsen IQ data from December 2024.

This translates to approximately $4.7 billion in lost sales.

Stock prices reflect investor anxiety.

Mondelez shares dropped 12% in October 2024 after management acknowledged GLP-1 headwinds.

Hershey fell 18% over the same period.

According to a Deloitte survey of 200 food industry executives conducted in November 2024, 73% cited GLP-1 medications as their top strategic concern.

This surpassed inflation (68%) and supply chain issues (54%) for the first time.

What Does “GLP-1 Friendly” Reformulation Actually Mean?

Companies are deploying multiple strategies to create products compatible with GLP-1 users’ needs.

The term “GLP-1 friendly” has emerged as industry shorthand for these reformulated products.

It is not a regulated designation.

Research indicates GLP-1 users have specific requirements that differ from traditional “diet” products.

Key Reformulation Strategies

Portion Reduction: Smaller serving sizes that match reduced appetite without feeling wasteful.

The average reformulated package contains 30-50% fewer calories than traditional versions.

Fiber Enhancement: Added soluble fiber helps GLP-1 users avoid gastrointestinal side effects.

According to research published in the Journal of Clinical Gastroenterology, fiber intake reduces GLP-1-related nausea by 34%.

Protein Fortification: Higher protein content addresses the muscle preservation concerns of GLP-1 users losing weight rapidly.

Studies show GLP-1 users lose 20-40% of weight as muscle mass without adequate protein intake.

Sugar Reduction: Lower sugar content aligns with the reduced sweet cravings GLP-1 users report.

Many users describe formerly appealing sweets as “too sweet” or “sickening.”

How Is Nestlé Leading the Reformulation Race?

Nestlé moved fastest among major food companies.

The Swiss giant launched its Vital Pursuit line in October 2024.

This became the first major product line explicitly designed for GLP-1 users.

The launch included 12 frozen meal and snack SKUs.

Each product contains at least 20 grams of protein.

Fiber content ranges from 7-12 grams per serving.

Calorie counts stay between 200-350 per serving.

Nestlé CEO Mark Schneider called it “the fastest product line ramp in company history.”

The company invested $350 million in dedicated manufacturing capacity.

Distribution expanded from initial test markets to 15,000 stores within 90 days.

The Vital Pursuit branding deliberately avoids “diet” language.

Market research showed GLP-1 users reject traditional weight-loss product positioning.

They view themselves as making medical choices, not dieting.

What Is PepsiCo’s Strategy for the GLP-1 Era?

PepsiCo took a different approach than Nestlé.

Rather than launching new brands, PepsiCo is reformulating existing favorites.

The company announced a $200 million R&D investment in November 2024.

This funds what executives call “portion optimization” across the Frito-Lay portfolio.

New package sizes launching in Q1 2025 include:

• Lay’s “Satisfier” bags at 1 oz (versus traditional 1.5 oz)
• Doritos “Smart Portions” at 0.875 oz
• Cheetos protein-enhanced varieties with 8g protein per serving
• Tostitos with added chicory root fiber

CEO Ramon Laguarta addressed analysts in December 2024.

He stated PepsiCo would “meet consumers where their appetite takes them.”

The strategy preserves brand equity while adapting to reduced consumption.

PepsiCo also acquired minority stakes in two functional snack startups.

These deals, totaling $85 million, provide access to high-protein crisp technology.

How Are Other Snack Giants Responding?

Mondelez International

The Oreo and Ritz maker partnered with registered dietitians in August 2024.

This advisory board guides reformulation priorities.

New fiber-enhanced Oreo Thins launched in test markets in December 2024.

Each cookie contains 3 grams of fiber from inulin.

Mondelez also reduced sugar by 25% without using artificial sweeteners.

Conagra Brands

The Slim Jim maker leaned into its existing protein positioning.

New “Slim Jim Protein Sticks” contain 15 grams of protein per serving.

Sales increased 28% year-over-year in the protein snack category.

Conagra acquired a plant-based jerky startup for $120 million in October 2024.

General Mills

The cereal giant repositioned Nature Valley as a GLP-1 compatible brand.

Marketing emphasizes fiber content and portion-controlled packaging.

New “Protein Crunchers” bars contain 12 grams of protein and 5 grams of fiber.

Kellogg’s (now WK Kellogg Co and Kellanova)

The company’s snack division, Kellanova, announced a “Nutrient Density Initiative.”

Pringles launched reduced-portion canisters in Europe as a test market.

Results showed 15% higher margins despite lower volumes.

Are These Reformulated Snacks Actually Healthier?

Nutrition experts offer mixed assessments.

The added fiber and protein provide genuine nutritional benefits.

However, some reformulations simply offer smaller portions without improved nutrition.

The FDA has not established standards for “GLP-1 friendly” claims.

This creates potential for misleading marketing.

Consumer advocacy groups have called for regulatory clarity.

The Center for Science in the Public Interest issued guidance in November 2024.

They recommend GLP-1 users prioritize:

• Minimum 5 grams of fiber per serving
• At least 10 grams of protein per serving
• Less than 5 grams of added sugar
• Whole food ingredients over processed alternatives

Medical professionals emphasize that no snack product replaces proper nutrition counseling.

GLP-1 users should work with healthcare providers on dietary plans.

How Are Consumers Reacting to GLP-1 Friendly Products?

Early consumer response data shows promising engagement.

A Harris Poll survey from December 2024 found 67% of GLP-1 users actively seek compatible snacks.

Of these, 78% expressed willingness to pay premium prices.

The average price premium for GLP-1 positioned products is 22%.

However, consumer confusion remains high.

Only 34% of surveyed GLP-1 users understood what made a product “GLP-1 friendly.”

Many relied on marketing claims rather than nutritional analysis.

Social media sentiment analysis by Brandwatch reveals interesting patterns.

Positive mentions of Nestlé’s Vital Pursuit increased 340% from October to December 2024.

The hashtag #GLP1Snacks generated 2.3 million TikTok views in November alone.

Influencer partnerships drive significant awareness.

GLP-1 lifestyle accounts with combined followings of 8 million regularly review reformulated products.

How Are Retailers Adapting Their Shelf Space?

Major retailers recognized the GLP-1 trend’s significance.

Walmart expanded its “Better For You” snack section by 35% in Q4 2024.

The retailer created dedicated endcaps for high-protein, high-fiber snacks.

Target launched a “Wellness Snacking” category in 850 stores.

Kroger’s data shows GLP-1 friendly products outperform traditional snacks by 2.5x on velocity.

Amazon’s grocery division created a “GLP-1 Supportive Foods” browse node in October 2024.

This category saw 180% month-over-month growth through year-end.

Private label development accelerated.

Costco’s Kirkland Signature launched four high-protein snack items in November 2024.

Trader Joe’s introduced a fiber-enhanced nut mix specifically positioned for GLP-1 users.

Whole Foods expanded its Vital Pursuit distribution to all 500+ stores.

The retailer reports the line as its fastest-growing frozen category.

What Does the Future Hold for Snacking in 2025-2027?

Industry analysts identify several key trends.

Personalization: Companies are exploring DNA-based and microbiome-informed snack recommendations.

Nestlé acquired a personalized nutrition startup for $180 million in December 2024.

Functional Ingredients: Expect increased use of prebiotics, adaptogens, and nootropics.

These additions target the wellness-focused GLP-1 demographic.

Subscription Models: Direct-to-consumer brands are launching GLP-1 snack subscription boxes.

Early entrant SnackWell (no relation to the 90s brand) raised $25 million in Series A funding.

What Should Investors Know About This Industry Shift?

Wall Street analysts have issued updated guidance across the food sector.

Morgan Stanley upgraded Nestlé to “Overweight” in December 2024.

The firm cited first-mover advantage in the GLP-1 space.

Conversely, pure-play confectionery stocks face headwinds.

Hershey received multiple downgrades through Q4 2024.

Private equity interest in functional food startups surged.

Deal volume in the “better-for-you” snack category increased 85% year-over-year.

Total disclosed deal value reached $2.3 billion in 2024.

Key metrics investors should monitor include:

• Percentage of revenue from reformulated products
• R&D spending on functional ingredients
• Distribution gains in wellness retail channels
• Consumer sentiment tracking among GLP-1 users